1054-1055 / 2953
Pooled estimated OS at 1 and 3 years
was
100% and 95% in SABR group;
88% and 79% in surgical group
Difference in OS
between the two
groups was statistically significant
This difference in OS is significant in
STARS alone but not in ROSEL alone
7 patients died:
6 in surgery group (2
PD, 1 secondary primary lung cancer, 1
surgical adverse event, 2 comorbidities)
and 1 in SABR group (PD)